Central regions | Finance, business

Russian biomed firm ready to sell antibodies to Europe

23 Jul '15
PrimeBioMed, an innovative Russian company, is ready to start exporting to the West its new antibodies to diagnose tumors, reported RVC, Russiaís fund of funds for innovation.

This has been made possible after this RVC portfolio company completed earlier this summer its ISO 13485 international standard certification procedure. The audit was conducted by Germanyís BSI Group Deutschland GmbH. PrimeBioMedís certificate is valid for three years.

The companyís plans for later this year and next year include the commercialization of its products internationally. PrimeBioMed is reported to be currently in talks over partnerships with medical centers in Italy and Switzerland.

PrimeBioMed has been in Russiaís biomed business for less than a year.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content


Latest News: Central regions
17 Oct '17 | Finance, business | Technology & innovation
13 Oct '17 | Finance, business | Retail, FMCG
12 Oct '17 | Finance, business | Technology & innovation

Feature stories

7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
20 Jun '17
In regions most of European Russians will hardly ever...
Search (News archive - 21174)
Marchmont News

Latest News

20 Oct '17
Infectex, a Russian biomed company, is readying for...
19 Oct '17
Russian scientists in partnership with their Korean...
18 Oct '17
Scientists at the Novosibirsk-based Boreskov...

Most read stories from last week

20 Oct '17
Infectex, a Russian biomed company, is readying for...